Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults
STOMPYA
2 other identifiers
interventional
503
1 country
2
Brief Summary
Legitimate prescription opioid use during adolescence has been associated with later prescription opioid misuse and substance use disorder symptoms during adulthood. Thus, primary prevention interventions for older adolescents and young adults (15-24 yrs) at the time of prescribing are imperative. The goal of our research is to improve opioid analgesic safety and efficacy by optimizing opioid risk recognition and informed decision-making among 15-24 year olds who are prescribed these agents for home use. Young adults and older adolescents who manage their own prescription pain medicines need to recognize opioid-related risks and make decisions that will both reduce these risks yet ensure effective pain relief. The proposed research will evaluate new strategies to help subjects learn about opioid risks and make safe and effective analgesic decisions. 355 subjects who are undergoing an elective surgical procedure will be recruited. Subjects will be randomized to receive the new educational routine information. Subjects' knowledge and perceptions will be evaluated at baseline and at critical times after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2019
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2019
CompletedFirst Posted
Study publicly available on registry
March 5, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedResults Posted
Study results publicly available
April 6, 2022
CompletedApril 6, 2022
March 1, 2022
2.1 years
February 21, 2019
December 22, 2021
March 13, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid Risk Perception
Perceived riskiness of opioid misuse (0-40 where 40 indicates highest risk perception)
Baseline, day 14, 3 months post intervention
Secondary Outcomes (1)
Opioid Misuse Intention Decisions
3 months post intervention
Study Arms (2)
Education Intervention
EXPERIMENTALThis group will receive the scenario-tailored STOMP educational feedback
Control
NO INTERVENTIONThis group will receive only standard of care information.
Interventions
This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.
Eligibility Criteria
You may qualify if:
- Undergoing an elective surgical procedure for which it is expected they will receive a prescription pain medicine for management of pain during recovery at home.
You may not qualify if:
- Undergoing non-elective procedure
- Cognitive impairment precluding self-reporting of pain
- Hematologic/oncologic condition
- Liver of kidney conditions precluding usual analgesic prescription patters (opioid plus a non-opioid)
- Use of opioids for prolonged pain pre-operatively (\<2 weeks)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (2)
University of Michigan, C.S. Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Terri Voepel-Lewis
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Terri Voepel-Lewis, PhD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Group assignment will be coded for subjects and data collectors. Subjects will be blinded to whether the information they receive is the Intervention vs. Control. Group assignment will coded on data entry and unblinded after analyses.
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
February 21, 2019
First Posted
March 5, 2019
Study Start
November 1, 2019
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
April 6, 2022
Results First Posted
April 6, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share